Westaim Corp subsidiary, NUCRYST Pharmaceuticals Corp (formerly Westaim Biomedical Corp), has moved its headquarters and R&D laboratories to Wakefield MA. It has also announced its intention to pursue opportunities for its silver nanocrystalline technology, the only nanotechnology of its type for healthcare applications. The decision to relocate follows successful trials and commercialization of its Acticoat-branded antimicrobial dressings. Acticoat has generated sales of US$15 million since its introduction in 1998. Westain’s corporate headquarters remain in Calgary....